Found 12 matching trials
Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC PHASE1 The purpose of this trial is to learn more about the effects of AAA602 and ...
Show More Location
Multiple Locations
Learn More & Join Trial
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan PHASE4 The purpose of this research study is to see how well an imaging test, call...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy PHASE4 Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (1...
Show More Learn More & Join Trial
Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCC PHASE2 This study is being conducted to test whether an imaging technique called a...
Show More Location
Washington University in St. Louis
Learn More & Join Trial
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy PHASE4 This clinical trial investigates the change in prostate-specific membrane a...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial PHASE2 This phase II trial tests how well relugolix and enzalutamide, in combinati...
Show More Location
Northwestern University
Learn More & Join Trial
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. PHASE3 The purpose of this study is to evaluate the efficacy and safety of lutetiu...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
Prostate MRI and Pylarify PSMA PET/CT PHASE4 This is a voluntary research study to find out how using technology includi...
Show More Location
Multiple Locations
Learn More & Join Trial
18F-DCFPyL PET/CT in Hepatocellular Carcinoma PHASE2 Background:
A radiotracer (or tracer) is a radioactive substance. It is us...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
A Phase 2 Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT. PHASE2 The purpose of this research is to test whether a new investigational Molec...
Show More Location
Hoag Family Cancer Institute
Learn More & Join Trial